Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Andrew Toy is Chief Executive Officer at Clover Health Investments, Corp.. OQRO lists 2 transactions filed with the SEC under this name, the latest on Oct 19, 2026, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
2
Companies involved
1
Clover Health Investments, Corp.CLOV
2 disclosures · Oct 2026 · 2 sold
Oct 15, 2026Sold~$291Kdisclosed Oct 19
DetailsOfficial recordOct 1, 2026Sold~$1.34Mdisclosed Oct 3
DetailsAndrew Toy has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
Andrew Toy reported 0 open-market purchases and 2 sales since 2026; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $1.63M2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , Andrew Toy reported holding 9,078,334 shares of Clover Health Investments, Corp. (CLOV), worth about $37.9M at the last close of $4 (Nov 18, 2026). In the last 12 months, Andrew Toy sold $1.63M in 2 sales.
Clover Health Investments, Corp.'s proxy statement reports total compensation of $1.32M for Andrew Toy for fiscal year 2025, after $9.48M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Apr 28, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Clover Health Investments, Corp. CLOV | 9,078,334 | 9.08M direct | $4 | $37.9M | Oct 15, 2026 |
Is this Andrew Toy’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Andrew Toy reported 0 open-market purchases and 2 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Oct 15, 2026, Andrew Toy reported holding 9,078,334 shares of Clover Health Investments, Corp. (CLOV). At the last close of $4 on Nov 18, 2026, that is about $37.9M. This is the stake disclosed in filings, not a net worth.
No public filing gives Andrew Toy's net worth. What SEC Form 4 shows is the stock stake: 9,078,334 shares of Clover Health Investments, Corp. (CLOV), about $37.9M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
In SEC filings of the last 12 months, Andrew Toy reported 2 open-market sales worth $1.63M, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Clover Health Investments, Corp.'s proxy statement reports total compensation of $1.32M for Andrew Toy for fiscal year 2025, after $9.48M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Andrew Toy has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
In SEC filings since 2026: no open-market purchase is on record; the latest open-market sale is from 2026.
Clover Health Investments, Corp. (CLOV), from 2026 to 2026: 0 purchases and 2 sales.